Zukowska-Szczechowska E, Moczulski D, Grzeszczak W, Gumprecht J
Katedry i Kliniki Chorób Wewnetrznych i Zawodowych Slaskiej AM w Zabrzu.
Pol Arch Med Wewn. 1996 Feb;95(2):125-34.
Disturbances of prolactin secretion occur both in the chronic renal failure and in diabetes mellitus. The study aimed to investigate if the diabetic nephropathy as a cause of chronic renal failure disturbs prolactin secretion. The study was conducted in 5 groups of patients: group I-12 patients with IDDM without diabetic nephropathy; group II-12 patients with IDDM with diabetic nephropathy treated conservatively; group III-16 patients with chronic renal failure of non-diabetic origin; group IV-12 patients with IDDM with end stage renal failure in the course of diabetic nephropathy treated with haemodialysis; group V-16 patients with end stage renal failure of non diabetic origin treated with haemodialysis. 12 healthy subjects served as the control group. In all investigated groups as well as in the control group the TRH test was performed. The mean serum prolactin concentration was estimated in the investigated groups just before the intravenous TRH injection and then after 15, 30, 45, 60 and 120 minutes. The mean area over the basic value (AOBV) of prolactin was also assessed. The patients with IDDM without diabetic nephropathy did not differ from healthy subjects both in the basic and TRH induced prolactin secretion. Basic and TRH induced prolactin secretion in patients with diabetic nephropathy both conservatively treated and treated with haemodialysis were lower than in patients with the same stage of chronic renal failure of non-diabetic origin.
慢性肾衰竭和糖尿病患者均会出现催乳素分泌紊乱的情况。该研究旨在调查作为慢性肾衰竭病因之一的糖尿病肾病是否会干扰催乳素分泌。研究选取了5组患者:第一组——12例无糖尿病肾病的胰岛素依赖型糖尿病(IDDM)患者;第二组——12例保守治疗的伴有糖尿病肾病的IDDM患者;第三组——16例非糖尿病源性慢性肾衰竭患者;第四组——12例在糖尿病肾病病程中处于终末期肾衰竭且接受血液透析治疗的IDDM患者;第五组——16例接受血液透析治疗的非糖尿病源性终末期肾衰竭患者。12名健康受试者作为对照组。对所有研究组以及对照组均进行了促甲状腺激素释放激素(TRH)试验。在静脉注射TRH之前以及之后的15、30、45、60和120分钟,对研究组的血清催乳素平均浓度进行了评估。还评估了催乳素高于基础值的平均面积(AOBV)。无糖尿病肾病的IDDM患者在基础及TRH诱导的催乳素分泌方面与健康受试者无差异。保守治疗及接受血液透析治疗的糖尿病肾病患者的基础及TRH诱导的催乳素分泌均低于处于相同阶段的非糖尿病源性慢性肾衰竭患者。